Total Credits: 1 including 1 AOA Category 1-A Credit(s), 1 AMA PRA Category 1 Credit(s)™
This program will expire and must be completed by 05/04/24.
In this presentation, Dr. Gates will discuss the entry point of COVID-19 and explain the pathway of the Bradykinin Storm. He will review medications that may weaken or intensify the Bradykinin Storm. Potential sequela will be examined, and he will discuss the patients most at risk for sequela of the Bradykinin Storm.
Objectives
Accreditation Statements:
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Creditä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The MAOPS Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
|
PPT - Sa8 - Dr. Lancer Gates - Bradykinin Storm Alert from Your COVID-19 Forecast Team
(71.76 MB)
|
Available after Purchase | ||
Dr. Lancer Gates started Gates Hospitalists, LLC in December of 2002. He is board certified in Internal Medicine by the American Osteopathic Board of Internal Medicine and the American Board of Internal Medicine. He is also a Fellow of the College of Osteopathic Internists. He received his Bachelor of Science degree in Pre-Medicine from Penn State University in University Park, Pennsylvania. Dr. Gates is a graduate of AT Still University Kirksville College of Osteopathic Medicine in Kirksville, Missouri. He completed his residency training at Wilson Memorial Regional Medical Center in Johnson City, New York.
Dr. Gates serves as the Council Vice-Chair of the Missouri State Medical Society (MSMA); serves on the Editorial Board of Missouri Medicine, the Journal of the Missouri State Medical Association; Chairperson of the MSMA Insurance Agency; member of the MSMA Committee for Legislative Affairs, the MSMA Ethics Committee; and is past President of the Kansas City Medical Society. He serves on the Board of Governors for the Kansas City Regional Osteopathic Medical Association and is the Secretary/Treasurer of the Kansas City Metropolitan Physicians Association. He also serves on the Finance Committee of Centrus Health. His honors include the 2008 Missouri Association of Osteopathic Physicians and Surgeons Physician of the Year and the 2007 Kansas City Society Doctor of Distinction. He serves as an Internal Medicine preceptor for osteopathic medical students.
Dr. Gates enjoys spending time with his family, running, vacationing in his native Pennsylvania, and being involved in Missouri politics.
Dr. Gates discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|